These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3405554)

  • 1. The prognostic importance of steroid receptors in endometrial carcinoma.
    Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
    Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
    Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid hormone receptor content and lymph node status in endometrial cancer.
    Morris PC; Anderson JR; Anderson B; Buller RE
    Gynecol Oncol; 1995 Mar; 56(3):406-11. PubMed ID: 7705676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
    Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
    Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
    McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
    Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of "nuclear" estrogen receptor content on prognosis of early stage carcinoma of the uterine body. A short-time follow-up.
    Horvath G; Johnsson JE; Tropé C; Samuelsson L; Alm P; Olsson H
    Neoplasma; 1990; 37(1):43-6. PubMed ID: 2320180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance].
    Kleine W; Fuchs A; deGregorio G; Geyer H
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
    Creasman WT; Soper JT; McCarty KS; McCarty KS; Hinshaw W; Clarke-Pearson DL
    Am J Obstet Gynecol; 1985 Apr; 151(7):922-32. PubMed ID: 3985057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma--relation between clinical aspects and histopathology].
    Gao YL
    Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):451-4. PubMed ID: 3836850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid receptor concentrations in endometrial carcinoma: effect on survival in surgically staged patients.
    Kadar N; Malfetano JH; Homesley HD
    Gynecol Oncol; 1993 Sep; 50(3):281-6. PubMed ID: 8406187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
    Hatae M; Yagi Y
    Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-year survival rate in endometrial carcinoma stage I-II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion.
    Lindahl B; Fernö M; Gullberg B; Norgren A; Willén R
    Anticancer Res; 1992; 12(2):409-12. PubMed ID: 1580559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endometrial cancer and steroid hormone receptors].
    Nyholm HC
    Ugeskr Laeger; 1990 Feb; 152(9):593-7. PubMed ID: 2408223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
    Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and progesterone receptors in uterine sarcomas.
    Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
    Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma.
    Demopoulos RI; Dubin N; Noumoff J; Blaustein A; Sommers GM
    Obstet Gynecol; 1986 Aug; 68(2):245-50. PubMed ID: 3737041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex steroid receptors in endometrial cancer.
    Chambers JT
    Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.